Task E02: Lead Optimization Screening Assays for ADMET

传染病介入性药物开发的非临床服务项目提供服务，以促进有前途的传染病病原体和/或毒素疗法的临床前产品开发。服务内容包括：临床前产品开发规划与评估；领导识别和开发；化学和GMP制造；体外和体内临床前微生物学，安全性，毒理学和药代动力学。

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.